Diabetic microangiopathy and urinary glycosaminoglycans

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 3, 1997, Pages 145-151

  Kahaly, G ^a   Hansen, Ch ^a   Otto, E ^a   Forster G ^a   Beyer, J ^a   Hommel, G ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Diabetic microangiopathy; Glycosaminoglycans; Insulin dependent diabetes mellitus

Indexed keywords

ACETIC ACID; CETYLPYRIDINIUM SALT; CREATININE; GLYCOSAMINOGLYCAN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030764563     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211743     Document Type: Article

References (33)

1. Baggio B, Briani E, Cicerello E, Gambaro G, Bruttomesso D, Tiengo A, Borsatti A, Crepaldi G: Urinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in non-albuminuric diabetic patients. Nephron 43: 187-190, 1986
2. Baggio B, Gambaro G, Cicerello E, Mastrosimone S, Marzaro G, Borsatti A, Pagano F: Urinary excretion of glycosaminoglycans in urological disease. Clin Biochem 20: 449-450, 1987
3. Bitter T, Muir HM: A modified uronic acid carbazole reaction: Anal Biochem 4: 330-334, 1962
4. Deckert T, Kofoed-Enevoldsen A, Vidal P, Norgaard K, Andreasen HB, Feldt-Rasmussen B: Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36: 244-251, 1993
5. Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T: Plasma disappearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus: evidence for charge dependent alterations of the plasma to lymph pathway. Diabetologia 36: 361-363, 1993
6. Gambaro G, Cicerello E, Mastrosimone S, Lavagnini T, Baggio B: High urinary excretion of glycosaminoglycans: a possible marker of glomerular involvement in diabetes. Metabolism 38: 419-420, 1989
7. Hansen C, Aichner C, Otto E, Beyer J, Kahaly G: Aberrant distribution and increased urinary glycosaminoglycan (GAG) excretion in type II diabetes mellitus (NIDDM). Exp Clin Endocrinol Diab 104: 145, 1996a
8. Hansen C, Fraiture B, Rouhi R, Otto E, Förster G, Kahaly G: HPLC glycosaminoglycan analysis in patients with Graves' disease. Clin Sci 92: 511-517, 1997
9. Hansen C, Irmscher A-K, Kuhlemann K, Beyer J, Kahaly G: Insulin-dependent diabetes mellitus and glycosaminoglycans. Horm Metab Res 27: 555-558, 1995.
10. Hansen C, Otto E, Kuhlemann K, Förster G, Kahaly GJ: Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol 14: 59-67, 1996b
11. Hansen C, Otto E, Beyer J, Kahaly G: Aberrant distribution of glycosaminoglycans in Graves' ophthalmopathy analysed by a new high specific HPLC method. J Endocrinol 148: 28, 1996c
12. Heickendorff L, Ledet T, Rasmussen LM: Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 37: 286-292, 1994
13. Kahaly G, Hansen C, Beyer J, Winand R: Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 17: 45-50, 1994a
14. Kahaly G, Hansen C, Stover C, Kuhlemann K, Beyer J, Otto E: Glycosaminoglycans and endocrine orbitopathy. Exp Clin Endocrinol 102: 151-161, 1994b
15. Kahaly G, Schuler M, Sewell, AC, Bernhard G, Beyer, J, Krause U: Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 33: 35-44, 1990
16. Kahaly G, Stover C, Beyer J, Otto E: In vitro synthesis of glycosaminoglycans in endocrine ophthalmopathy. Acta Endocrinol 127: 397-402, 1992a
17. Kahaly G, Stover C, Otto E, Beyer J, Schuler M: Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity 13: 81-88, 1992b
18. Kanwar YS, Rosenzweig LJ, Linker A, Jakubowski ML: Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci USA 80: 2272-2275, 1983
19. Lubec G, Legenstein E, Pollak A, Meznik E: Glomerular basement membrane changes, HBA1c and urinary excretion of acid glycosaminoglycans in children with diabetes mellitus. Clin Chim Acta 103: 45-49, 1980
20. Mogensen CE: Management of diabetic renal involvement and disease. Lancet I: 867-869, 1988a
21. Mogensen CE: On definition of diabetic renal disease in IDDM, based on renal function tests. In: Mogensen CE (ed). The Kidney and Hypertension in Diabetes Mellitus. M Nijhoff Publishing, Boston, 1988b
22. Monciotti C, Oliva O, Gambaro G et al: Glycosaminoglycan urinary excretion in young diabetic patients. Pediatric and Adolescent Endocrinology 18: 213-216, 1989
23. Moran A, Brown DM, Kim Y, Klein DJ: Effects of IGF-1 and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture. Diabetes 40: 1346-1354, 1991
24. Newton DJ, Scott JE, Ahmad S: Circadian rythmus and the urinary excretion of acid glycosaminoglycans in normal human adults. Connective Tissue Research 7: 47-55, 1979
25. Pfeiffer A, Schatz H: Diabetic microvascular complications and growth factors. Exp Clin Endocrinol 103: 7-14, 1995
26. Poulsen JH: Urine and tissue glycosaminoglycans and their interrelations. Dan Med Bull 33: 75-96, 1986
27. Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N: Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem Med Metab Biol 45: 119-31, 1991
28. Schuler M, Hansen C, Winand R, Stover C, Otto E, Beyer J, Kahaly G: Urinary and plasma glycosaminoglycans in endocrine ophthalmopathy. In: Kahaly G (ed). Endocrine ophthalmopathy. Molecular, immunological and clinical aspects. Karger publishers, Basel, 1993
29. Shield JP, Carradus M, Stone JE, Hunt LP, Baum JD, Pennock CA: Urinary heparan sulphate proteoglycan excretion is abnormal in insulin dependent diabetes. Ann Clin Biochem 32: 557-560, 1995
30. Shimomura H, Spiro RG: Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes: decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36: 347-381, 1987
31. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L: Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108: 869-872, 1990
32. Tamsma JT, van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, van der Woude FJ: Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320, 1994
33. Wasty F, Alavi MZ, Moore S: Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 36: 316-322, 1993